Recent Advances in Neurology

Significant developments were published in 2020 in the field of blood biomarkers in Alzheimer's disease. Several studies helped to define more accurately the management of status epilepticus and of epilepsy in women of childbearing age. The new Swiss guidelines for the pre-hospital management o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Revue médicale suisse 2021-01, Vol.17 (723), p.196
Hauptverfasser:	Anichini, Angelica, Salvioni Chiabotti, Paolo, Bally, Julien, Castro Jimenez, Mayte, Démonet, Jean-François, Di Virgilio, Gabriella, Hirt, Lorenz, Hottinger, Andreas, Kuntzer, Thierry, Michel, Patrik, Novy, Jan, Pot Kreis, Caroline, Rossetti, Andrea O, Rouaud, Olivier, Théaudin, Marie, Du Pasquier, Renaud
Format:	Artikel
Sprache:	fre
Schlagworte:	COVID-19 Female Humans Neurology Neuromyelitis Optica - epidemiology Pandemics SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Significant developments were published in 2020 in the field of blood biomarkers in Alzheimer's disease. Several studies helped to define more accurately the management of status epilepticus and of epilepsy in women of childbearing age. The new Swiss guidelines for the pre-hospital management of acute stroke were issued, as are new targets for stroke prevention. Numerous advances concerning the management of NMO-SD (NeuroMyelitis Optica Spectrum Disorder) were published. Different neurological presentations linked to the COVID-19 pandemic were described (central and peripheral). Several studies confirmed the effectiveness of new migraine treatments (including anti-CGRP). New pharmacological therapies are available for Parkinson's disease.
ISSN:	1660-9379